Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1137

Protein-sucrose

Intended Use: Intended to be used at levels ranging from 0.01 to 0.8% on a protein basis to improve the perception of sweetness of white granulated sugar.
Basis: Scientific procedures
Notifier: Incredo Ltd.
Notifier Address: 9 Shimson Street
Petach-Tikva 49517
Israel
GRAS Notice (releasable information): GRN 1137 with amendments (in PDF) (8.9 MB)
Date of closure: Jan 19, 2024
FDA's Letter: FDA has no questions (in PDF) (188 kB)
-
-